Skip to main content
Premium Trial:

Request an Annual Quote

Rohm and Haas Donates RheoGene Assets to University of Pittsburgh Medical Center

NEW YORK, Feb. 17 (GenomeWeb News) - Specialty chemical company Rohm and Haas has donated the intellectual property and material assets of gene expression firm RheoGene -- worth approximately $30 million -- to The University of Pittsburgh Medical Center, UPMC said today.

The donation includes RheoGene's intellectual property, equipment, compounds, biological materials, research, and commercial agreements and licenses. The company -- founded in 1999 as a joint venture between Rohm and Haas and Upstate Inc. -- will maintain key business and technical personnel at its Norristown, Pa., location following the acquisition.

The company said it also plans to open a clinical laboratory in Pittsburgh during 2004 to facilitate collaborations with UPMC, the University of Pittsburgh, and other life sciences institutions in western Pennsylvania.

RheoGene has developed technology called RheoSwitch to manage gene expression via small-molecule mediators that can up- or down-regulate genes "in a manner analogous to a rheostat control on a light switch," according to the company. RheoGene said that it has just begun pre-clinical testing of the technology.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.